Inrobics
PrivateLast Round
VC Round
Jul 9, 2026
Est. Valuation
$1.38M
Total Funding Raised
$350,000
Company Overview
Inrobics operates in Healthcare & Life Sciences and is based in Madrid. Its latest recorded funding round was a Seed round in August 2022.
Inrobics is a digital health company that provides a platform with personalized rehabilitation services through social robots and artificial intelligence for individuals with functional or neurological limitations.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Patient Engagement, Telemedicine
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inrobics Comparables
Compare Inrobics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 株式会社デジリハ | 76% | |
| Life Science Robotics | 73% | |
| Tyromotion | 69% |
For institutional investors. Book with your work email.
Inrobics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 9, 2026 | ||||
| Early Funding | Mar 18, 2024 | ||||
| Seed | Aug 8, 2022 | ||||
| Angel | Jun 24, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inrobics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startupxplore | VC Round |
| Grow Venture Partners | Seed, VC Round |
| Cell Capital | Seed |
| Capital Cell | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2021
Raised an Angel round with Universidad Carlos III de Madrid.
For institutional investors. Book with your work email.
Inrobics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inrobics's valuation, stock price, and market status.
Is Inrobics a public or private company?
Inrobics is a private company.
What is the current stock price of Inrobics?
Inrobics is a private company, so its shares have no public market price. Caplight tracks Inrobics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inrobics worth (valuation)?
Inrobics's valuation is estimated at $1.4M based on funding round data.
Can I buy Inrobics stock?
Inrobics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inrobics's last funding round?
Inrobics's most recent funding round was VC Round on July 9, 2026.
Who are the main investors in Inrobics?
Key investors in Inrobics include Grow Venture Partners.
Will Inrobics IPO soon?
No public IPO plans have been announced for Inrobics.
How can I track Inrobics secondary market activity?
Caplight tracks bids, offers, and trades in Inrobics's shares on secondary markets.